Literature DB >> 11286798

Dinitroaniline herbicides against protozoan parasites: the case of Trypanosoma cruzi.

Y M Traub-Cseko1, J M Ramalho-Ortigão, A P Dantas, S L de Castro, H S Barbosa, K H Downing.   

Abstract

The drugs presently in use against Chagas disease are very toxic, inducing a great number of side effects. Alternative treatments are necessary, not only for Chagas disease but also for other diseases caused by protozoan parasites where current drugs pose toxicity problems. The plant microtubule inhibitor trifluralin has previously been tested with success against Leishmania, Trypanosoma brucei and several other protozoan parasites. Trypanosoma cruzi, the causative agent of Chagas disease, is also sensitive to the drug. This sensitivity has been correlated with the deduced amino acid sequences of alpha- and beta-tubulin of T. cruzi as compared with plant, mammal and other parasite sequences.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11286798     DOI: 10.1016/s1471-4922(00)01834-1

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  16 in total

1.  Leishmania tarentolae: purification and characterization of tubulin and its suitability for antileishmanial drug screening.

Authors:  Adam J Yakovich; Frank L Ragone; Juan D Alfonzo; Dan L Sackett; Karl A Werbovetz
Journal:  Exp Parasitol       Date:  2006-06-05       Impact factor: 2.011

2.  Molecular basis for resistance of acanthamoeba tubulins to all major classes of antitubulin compounds.

Authors:  Fiona L Henriquez; Paul R Ingram; Stephen P Muench; David W Rice; Craig W Roberts
Journal:  Antimicrob Agents Chemother       Date:  2007-12-10       Impact factor: 5.191

3.  Microtubules in plants.

Authors:  Takashi Hashimoto
Journal:  Arabidopsis Book       Date:  2015-04-27

Review 4.  Microtubule drugs: action, selectivity, and resistance across the kingdoms of life.

Authors:  V Dostál; L Libusová
Journal:  Protoplasma       Date:  2014-03-21       Impact factor: 3.356

5.  Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin.

Authors:  Christopher Ma; Johnson Tran; Frank Gu; Roxanna Ochoa; Catherine Li; David Sept; Karl Werbovetz; Naomi Morrissette
Journal:  Antimicrob Agents Chemother       Date:  2010-02-09       Impact factor: 5.191

6.  Post-translational modifications to Toxoplasma gondii alpha- and beta-tubulins include novel C-terminal methylation.

Authors:  Hui Xiao; Kamal El Bissati; Pascal Verdier-Pinard; Berta Burd; Hongshan Zhang; Kami Kim; Andras Fiser; Ruth Hogue Angeletti; Louis M Weiss
Journal:  J Proteome Res       Date:  2010-01       Impact factor: 4.466

7.  Secondary mutations correct fitness defects in Toxoplasma gondii with dinitroaniline resistance mutations.

Authors:  Christopher Ma; Johnson Tran; Catherine Li; Lakshmi Ganesan; David Wood; Naomi Morrissette
Journal:  Genetics       Date:  2008-09-09       Impact factor: 4.562

8.  Mutations in alpha-tubulin confer dinitroaniline resistance at a cost to microtubule function.

Authors:  Christopher Ma; Catherine Li; Lakshmi Ganesan; Jean Oak; Susan Tsai; David Sept; Naomi S Morrissette
Journal:  Mol Biol Cell       Date:  2007-09-19       Impact factor: 4.138

9.  Synthesis, biological evaluation, and molecular modeling of 3,5-substituted-N1-phenyl-N4,N4-di-n-butylsulfanilamides as antikinetoplastid antimicrotubule agents.

Authors:  Tesmol G George; Molla M Endeshaw; Rachel E Morgan; Kiran V Mahasenan; Dawn A Delfín; Mitali S Mukherjee; Adam J Yakovich; Jean Fotie; Chenglong Li; Karl A Werbovetz
Journal:  Bioorg Med Chem       Date:  2007-06-27       Impact factor: 3.641

10.  Dinitroanilines bind alpha-tubulin to disrupt microtubules.

Authors:  Naomi S Morrissette; Arpita Mitra; David Sept; L David Sibley
Journal:  Mol Biol Cell       Date:  2004-01-23       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.